Characterization of DNA polymerase β from Danio rerio by overexpression in E. coli using the in vivo/in vitro compatible pIVEX plasmid
Eukaryotic DNA polymerase β (pol β), the polymerase thought to be responsible for DNA repair synthesis, has been extensively characterized in rats and humans. However, pol β has not been purified or enzymatically characterized from the model fish species Danio rerio (zebrafish). We used the in vitro/in vivo dual expression system plasmid, pIVEX, to express Danio rerio pol β (Danio pol β) for biochemical characterization.
Danio pol β encoded by the in vitro/in vivo-compatible pIVEX plasmid was expressed in E. coli BL21(DE3), BL21(DE3)pLysS, and KRX, and in vitro as a C-terminal His-tagged protein. Danio pol β expressed in vitro was subject to proteolysis; therefore, bacterial overexpression was used to produce the protein for kinetic analyses. KRX cells were preferred because of their reduced propensity for leaky expression of pol β. The cDNA of Danio rerio pol β encodes a protein of 337 amino acids, which is 2-3 amino acids longer than other pol β proteins, and contains a P63D amino acid substitution, unlike mammalian pol βs. This substitution lies in a hairpin sequence within an 8-kDa domain, likely to be important in DNA binding. We performed extensive biochemical characterization of Danio pol β in comparison with rat pol β, which revealed its sensitivity to metal ion activators (Mn2+ and Mg2+), its optimum salt concentration (10 mM KCl and 50 mM NaCl), alkaline pH optimum (pH 9.0), and low temperature optimum (30°C). Substituting Mn2+ for Mg2+ resulted in 8.6-fold higher catalytic efficiency (kcat/Km).
Our characterization of pol β from a model fish organism contributes to the study of the function and evolution of DNA polymerases, which are emerging as important cellular targets for chemical intervention in the development of anticancer agents.
KeywordsOptimum Salt Concentration Important Cellular Target dNTP Binding pIVEX Plasmid dNTP Binding Pocket
In eukaryotic cells, nuclear DNA replication and repair relies on five species of DNA polymerases (pols): α, β, γ, δ and ε [1, 2, 3]. Additional DNA pols have been discovered, namely, pol λ, μ, ζ, η, θ, ι,κ, σ and REV1 [4, 5]. These pols have emerged as important cellular targets for chemical intervention in the development of anticancer agents [6, 7]. Of these pols, pol β is thought be involved in DNA repair synthesis . This enzyme belongs to family X, which includes pol λ, μ, and terminal deoxynucleotidyltransferase (TdT). Pol β is the smallest polymerase in family X. Other members of the family have a nuclear localization signal (NLS), a BRCA1 C-terminal (BRCT) domain, and a proline rich region. Mammalian pol β is a single polypeptide of 39 kDa, comprising 335 amino acids forming two domains: an 8 kDa N-terminal domain and a 31 kDa C-terminal domain, connected with a protease-hypersensitive hinge region. The former domain possesses a template-binding function and a dRPase activity to remove the 5'-deoxyribose phosphate, the latter domain possesses DNA polymerase activity. Biochemical studies have shown that pol β releases the 5'-terminal dRP residues from the aprinic/apyrimidinic sites and fills short gaps of one to six nucleotides. These activities indicate that pol β functions in base excision repair (BER), which is a major pathway for repairing modified bases in DNA .
Both rat and human pol β genes have been cloned, the crystal structures were determined, and an active recombinant enzyme has been overexpressed in Escherichia coli. However, only a few papers on the properties of pol β from lower vertebrates, particularly from the fish kingdom, such as Oncorhynchus masou (cherry salmon)  and Xiphophorus maculaus, have been reported.
Danio rerio (zebrafish) has long been used as a model organism in the fields of molecular genetics and developmental biology of vertebrates . D. rerio constitutes a powerful animal model, largely because of their small size, optical clarity, fecundity, rapid development, and large arsenal of readily available genetic tools . The D. rerio model system is amenable to whole-genome forward genetic approaches, which facilitates experimental manipulation and allows the direct observation of tissue formation and organogenesis in vivo. Thus, research using D. rerio has allowed advances in fields such as developmental biology, oncology, toxicology, and regenerative medicine [16, 17, 18]. However, the purification and enzymatic characterization of pol β from D. rerio has not been reported.
The pIVEX plasmid, which is optimized in the Rapid Translation System (RTS) as cell-free protein expression system, is a useful compatible vector for both in vivo and in vitro expression systems based on E. coli, pIVEX permits comparison between cell-free and bacterial expression from the same genetic construct . The pIVEX vector system is particularly useful for (i) bacterial expression after cell-free expression for scale-up of protein expression and solution of problems such as poor protein yields or expression results, and (ii) cell-free expression when the recombinant protein cannot be expressed in bacteria cells. In fact, in the present study, we found pIVEX carrying the Danio rerio pol β (Danio pol β) cDNA causes growth inhibition of BL21(DE3)pLysS cells before expression induction, which contrasted with other proteins that were reported to be expressed in the pIVEX vector system using BL21(DE3)pLysS cells [19, 20]. Thus, the determination of the correct plasmid/host combination is required for the expression certain proteins.
In the present study, we report the overproduction and enzymatic characterization of Danio pol β using the pIVEX plasmid in E. coli. We revealed that Danio pol β was overproduced in the E. coli expression host by substituting ordinary BL21(DE3) cells with KRX cells. The enzymatic properties of the purified recombinant Danio pol β were examined and compared with rat pol β. The Michaelis constants, Km and kcat, and the catalytic efficiencies (kcat/Km) for recombinant Danio pol β were also determined by pol β-mediated nucleotide incorporation during primer extension.
Results and Discussion
Comparison of amino acids sequences among various pol βs
Growth rate of E. coli cells transformed with pIVEX
Overexpression of Danio pol β
To compare both in vivo and in vitro expression, we used the same pIVEX plasmid encoding Danio pol β. Figure 3B shows that Danio pol β was produced in a cell-free expression system using the pIVEX plasmid. From the western blotting analysis using anti-His6-antibody, proteolysis of Danio pol β occurred during in vitro expression (Figure 3B). As a result, bacterial expression was preferred to cell-free expression for Danio pol β.
Enzymatic characterization of recombinant Danio rerio pol β
We then examined the activity of Danio pol β at various temperatures, from 15°C to 50°C, and compared it with the rat polymerase activity. Figure 6B shows that Danio pol β was most active at 30°C and decreased by 50% at 35°C compared with the highest activity. Danio pol β was relatively sensitive to temperature compared with rat pol β. Furthermore, the optimum temperature of Danio pol β was lower than that of rat pol β (37°C). This observation corresponds to the lower temperature generally required by fish compared with the warmer body temperatures of humans and rats [11, 12]. The fish and frog pol β proteins contain the P63D variation compared with mammalian pol β proteins. This difference might represent an important evolutionary mutation between cold-blooded and homeothermic organisms . Indeed, Danio pol β also has the P63D variation (Figure 1).
Kinetic assays of Danio pol β
Kinetics of Danio pol β in the presence of Mg2+ or Mn2+
kcat/Km × 103 [μM-1 min-1]
We have succeeded in overproducing, purifying, and characterizing Danio pol β. Using a suitable plasmid/host combination, Danio pol β encoded by the in vitro/in vivo compatible pIVEX plasmid was expressed in E. coli KRX. This combination was able to tightly suppress leaky expression of Danio pol β, which is a toxic protein for bacterial cell growth. The pIVEX/KRX combination required only one antibiotic, unlike previous work using two antibiotics because of the requirement for an extra plasmid, such as pLysS. This combination also forms an important tool for proteomics and structural biology, with its potential to express a variety of (growth toxic) recombinant proteins in both in vitro and in vivo. Furthermore, we performed extensive biochemical characterization of Danio pol β, which revealed its sensitivity to metal ion activators, its optimum salt concentration, alkaline pH optimum, and low temperature optimum. From the kinetic assays, we found that substituting Mn2+ for Mg2+ resulted in 8.6-fold higher catalytic efficiency (kcat/Km). Mn2+ is considered a potential mutagen, and further experiments to investigate the sensitivity and fidelity with metal ion activators for Danio pol β are underway. Moreover, we characterized pol β from the D. rerio fish model. Pol β is the smallest polymerase in eukaryotes, and it can be regarded as a basic model of various DNA polymerases. Our characterization of pol β from a model fish organism contributes to the study of the function and evolution of DNA polymerases.
Construction of the pIVEX-Danio pol β expression plasmid
A 1019-bp cDNA sequence of Danio pol β [DDBJ: AY648826] was artificially synthesized and codon-optimized for E. coli expression (Operon Biotechnologies). To clone the cDNA into pIVEX 2.3d vector (5 Prime), which expresses the protein with a C-terminal His6-tag, the synthesized cDNA was amplified by PCR using primers designed against the 5' and 3' conserved region of the cDNA, and the high fidelity Phusion DNA polymerase (Finnzyme). An additional 15 bp was included in each primer, which corresponded to upstream and downstream bases of the pIVEX 2.3d vector to enable ligation-independent In-Fusion cloning (Clontech). The primers were: forward primer 5'-AGG AGA TAT ACC ATG AGC AAA CGT AAA GCC CCT-3' and reverse primer 5'-ATG AGA ACC CCC CCC TTC TGA GCG ATC TTT TGG-3'. The underlined regions represent the Danio rerio pol β-specific sequence. The PCR products were separated on a 1% agarose gel and the band corresponding to the expected cDNA coding sequence was isolated. The gel-isolated DNA fragment was purified by ethanol precipitation and inserted into linearized pIVEX vector, which was digested at the multiple cloning site by Nco I and Sma I, using the In-Fusion system (Clonetech), according to the manufacturer's instruction. The integrity of the nucleotide sequence of the constructed plasmid was confirmed by DNA sequencing.
Overexpression and purification of Danio rerio pol β
Plasmid pIVEX-pol β was used to transform E. coli KRX (Promega), BL21(DE3) (Nippon Gene), and BL21(DE3)pLysS (Novagen) cells for expression of Danio pol β. Transformed cells were plated and cultured on LB plates containing ampicillin (100 μg/ml) at 37°C overnight. Individual bacterial colonies were grown overnight in 5 ml of LB medium supplemented with ampicillin (100 μg/ml) at 30°C to a cell density of 0.6 OD600. During this pre-culturing, the OD600 value was recorded at 30 min intervals with an optical density monitor (Taitech). The next day, a fresh 1% inoculum was added into 200 ml of LB medium containing 100 μg/ml ampicillin at 25°C until an OD600 of approximately 0.8 was reached. At this point, 1% rhamnose (Promega) was added to the growth culture of KRX E. coli containing pIVEX-pol β for induction of recombinant protein expression. Cells were harvested by centrifugation at 3300 × g for 10 min, gently suspended in 20 ml lysis buffer (300 mM KCl, 50 mM KH2PO4, 5 mM imidazole, pH 8.0) and sonicated on ice (20 times, 30 s). After centrifugation at 5800 × g for 30 min, the soluble fraction was filtered through a 0.45 μm pore-membrane (Millipore). Recombinant protein was purified and its buffer was exchanged using the Profinia protein purification system (Bio-Rad). Recombinant protein in the soluble fraction was applied to an Ni2+-NTA affinity chromatography column with 1 ml column volume (Bio-Rad) previously equilibrated with wash buffer 1 (50 mM potassium phosphate, pH 8.0, 300 mM KCl, 5 mM imidazole). The column was allowed to equilibrate with the lysate and the unbound protein was eluted from the column with six column volumes of wash buffer 1, followed by elution of weakly bound protein with six column volumes of wash buffer 2 (50 mM potassium phosphate, pH 8.0, 300 mM KCl, 10 mM imidazole). Tightly bound fusion protein was eluted with three column volumes of elution buffer (50 mM potassium phosphate, pH 8.0, 300 mM KCl, 250 mM imidazole). The eluted protein was applied to a gel chromatography column (Bio-Rad) previously equilibrated phosphate buffer saline (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 8.1 mM KH2PO4, pH 7.4) for desalting of the elution buffer. The purified protein was concentrated at ~2 mg/ml by ultrafiltration using an Amicon Ultra filter (MWCO: 10 K, Millipore) by centrifugation for 30 min at 8000 × g at 4°C. The same volume of glycerol was added to the concentrated sample solution to make an approximately 1 mg/ml stock sample solution in 50% (v/v) glycerol for storage at -80°C. The production yield of the recombinant protein was evaluated by determining the amount of the purified protein against the volume of the culture. The amount of the purified protein was determined using the Bradford method. One milliliter of 1:5 diluted dye solution (Bio-Rad) was added to 100 μl of the purified protein and standards protein of bovine serum albumin. After incubation for 5 min at room temperature, an absorbance at 595 nm was measured. The amount of purified protein was determined by measuring the absorbance and referring to a calibration curve generated using the standard protein. Recombinant rat pol β was expressed and purified from E. coli as described by Date et al. . Cell-free expression of Danio pol β and rat pol β was performed in RTS100 E. coli HY (5 Prime), as described in the instruction manual. Recombinant protein production was carried out in a 50 μl volume with 0.5 μg of pIVEX-pol β plasmid for 6 hours at 30°C. The expressed proteins from both in vivo and in vitro extracts were examined by SDS-polyacrylamide gel electrophoresis and subsequently detected by Coomassie brilliant blue staining and western blotting.
DNA polymerization assay
The template and digoxigenin (DIG)-labeled primer used in the activity assay were purchased from Sigma-Aldrich. The primers were labeled with DIG at the 5' end for subsequent detection in Southern blotting. The DIG-primer, 5'-GGA GGA TGG CAG CGT GAG GG-3', annealed to the templates (5'-AAA AAC CCT CAC GCT GCC ATC CTC C-3') at a 1:1.2 molar ratio when heated at 95°C for 5 min and then at 65°C for 20 min, followed by immediate cooling on ice. The prepared primer-template complex (5 μM) was stored on ice until required.
Reactions for determining Danio pol β activity were performed in a 10 μl reaction mixture, containing 50 mM Tris-HCl (pH 8.8), 1 mM dithiothreitol (DTT), 100 μg/ml bovine serum albumin (BSA), 100 mM KCl, 1 mM MgCl2, 0.5 μM primer-template, 10 μM dTTP, and 0.1 mg/ml Danio pol β. The reaction mixtures were incubated at 30°C for 5 min and the reaction was terminated by the addition of 7 μl stop solution (95% formamide, 20 mM ethylenediaminetetraacetic acid, 0.05% bromophenol blue, and 0.05% xylene cyanol FF).
To compare the activity of Danio pol β with rat pol β, the reaction of rat pol β activity was performed in a 10 μl reaction containing 50 mM Tris-HCl (pH 8.0), 2 mM DTT, 150 mM KCl, 5 mM MgCl2, 0.5 μM primer-template, 10 μM dTTP and 0.1 mg/ml rat pol β. The reaction mixture was incubated at 37°C for 5 min, and 7 μl of stop solution was added to quench the reaction.
Products were analyzed by sequencing gel electrophoresis. Each quenched reaction mixture was incubated at 95°C for 5 min, and then analyzed by electrophoresis under denaturing conditions [12% acrylamide, 7 M urea, and sodium taurine (ST) running buffer] for 2.5 h with the power supply fixed at 40 W during electrophoresis [29, 30]. Following electrophoresis, the gel was contact-blotted onto a positively charged nylon membrane (Roche) for 45 min and then cross-linked (200 mJ/cm2) using light at a wavelength of 254 nm. The membrane was incubated in a blocking buffer [0.1 M maleic acid, 0.15 M NaCl pH 7.5, 1% (w/v) blocking reagent; Roche] on a rocking platform for 30 min. The blocked membrane was incubated with anti-DIG-AP Fab fragments (Roche) diluted 1:50,000 in blocking buffer for 60 min. The membrane was washed three times with wash buffer (0.1 M maleic acid, 0.15 M NaCl, pH 7.5, 0.3% Tween 20) for 20 min each. The membrane was then incubated in detection buffer (0.1 M Tris-HCl pH 9.5, 0.1 M NaCl) on a rocking platform for 20 min. Finally, the membrane was incubated with CDP Star (Roche) at a 1:500 dilution in detection buffer for 10 min. The membrane was exposed to X-ray film (Fuji Film) in the dark and the film developed in a medical film processor (FPM100; Fuji Film).
Kinetic assays of Danio rerio pol β
Kinetic Incorporation of dTTP (Takara) by pol β of Danio rerio or rat was performed in the same reaction buffer and temperature (30°C) that was used for the respective DNA polymerization assay in a total volume of 10 μl containing 0.5 μM of the primer-template complex. The concentrations of dTTP use were 3.75, 5, 7.5, 10, 15, and 20 μM. The reaction mixture was incubated for 5 min. The kinetics of dTTP incorporation were determined using sequencing gel assay [31, 32]. The velocity of the reaction, v (amount of extension products per minute), was calculated from the ratio of the amount of extended products to the total amount of primer in each lane. The Km and the maximum velocity (Vmax) for dTTP incorporation were calculated using least-square fitting from a Hanes-Woolf plot of [dTTP]/v against [dTTP]. The Kcat was calculated by dividing Vmax by the enzyme concentration. The amount of extended product was estimated from the intensity of each band following subsequent sequencing electrophoresis analysis with GelPro Analyzer software (Media Cybernetics).
This work was supported by a grant from the Industrial Technology Research Program from the New Energy and Industrial Technology Development Organization (NEDO), Japan.
- 5.Burgers PM, Koonin EV, Bruford E, Blanco L, Burtis LC, Christman MF, Copeland WC, Friedberg EC, Hanaoka F, Hinkle DC, Lawrence CW, Nakanishi M, Ohmori H, Prakash L, Prakash S, Reynaud C-A, Sugino A, Todo T, Wang Z, Weill J-C, Woodgate R: Eukaryotic DNA polymerases: proposal for a revised nomenclature. J Biol Chem. 2001, 276: 43487-43490. 10.1074/jbc.R100056200CrossRefGoogle Scholar
- 6.Fry M, Loeb LA: Animal Cell DNA Polymerases. 1986, Boca Raton, FL: CRC Press,Google Scholar
- 8.Kornberg A, Baker TA: DNA replication. 1992, Sausalito, CA: University Science Books, 2,Google Scholar
- 11.Yamaguchi T, Nishimura S, Takahashi K, Yoshikuni M, Masaki J, Hirai T, Saneyoshi M: DNA polymerase βs from liver and testes of Cherry Salmon, Oncorhynchus masou: Purification and characterization of DNA polymerase βs with acidic isoelectric points. J Biochem. 1996, 119: 186-192.CrossRefGoogle Scholar
- 12.Oehlers LP, Heater SJ, Rains JD, Wells MC, David WM, Walter RB: Gene structure, purification and characterization of DNA polymerase β from Xiphophorus maculatus. Comp Biochem Phys C. 2004, 138: 311-324.Google Scholar
- 15.Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CDM, Morris JP, Liu TX, Schulte-Merker S, Kanki JP, Plasterk R, Zon LI, Look AT: tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci USA. 2005, 102: 407-412. 10.1073/pnas.0406252102CrossRefGoogle Scholar
- 22.Hartnett JH, Gracyalny MSJ, Slater MR: The single step (KRX) competent cells: Efficient cloning and high protein yields. Promega Notes. 2006, 94: 27-30.Google Scholar
- 25.Margerum DW, Cayley GR, Weatherburn DC, Pagenkopf GK: Coordination Chemistry. Edited by: Martell AE. 1978, 1-200. Vol. 2., Washington, DC: American Chemical Society,Google Scholar
- 31.Boosalis MS, Petruska J, Goodman MF: DNA polymerase insertion fidelity: gel assay for site-specific kinetics. J Biol Chem. 1987, 262: 14689-14696.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.